Comparison between success rates for smokers re-treated by a
smokers' clinic and success rates for smokers treated for the
first time

J 2021

Comparison between success rates for smokers re-treated by a smokers' clinic and success rates for smokers treated for the first time

STEPANKOVA, Lenka, Eva KRALIKOVA, Kamila ZVOLSKA, Alexandra PANKOVA, Zuzana ADAMCEKOVA et. al.

Základní údaje

Originální název

Comparison between success rates for smokers re-treated by a smokers' clinic and success rates for smokers treated for the first time

Autoři

STEPANKOVA, Lenka (203 Česká republika, garant), Eva KRALIKOVA (203 Česká republika), Kamila ZVOLSKA (203 Česká republika), Alexandra PANKOVA (203 Česká republika), Zuzana ADAMCEKOVA (203 Česká republika), Matyáš KUHN (203 Česká republika, domácí) a Derek NOLAND (840 Spojené státy)

Vydání

ADDICTION, HOBOKEN, WILEY, 2021, 0965-2140

Další údaje

Jazyk

angličtina

Typ výsledku

Článek v odborném periodiku

Obor

30312 Substance abuse

Stát vydavatele

Spojené státy

Utajení

není předmětem státního či obchodního tajemství

Odkazy

URL

Impakt faktor

Impact factor: 7.256

Kód RIV

RIV/00216224:14110/21:00120695

Organizační jednotka

Lékařská fakulta

DOI

http://dx.doi.org/10.1111/add.15175

UT WoS

000549501100001

Klíčová slova anglicky

Mental health; nicotine; re-treatment; tobacco; tobacco dependence; tobacco use disorder; pharmacotherapy; varenicline

Štítky

14119612, podil, rivok

Příznaky

Mezinárodní význam, Recenzováno

Změněno: 10. 8. 2023 09:52, Mgr. Marie Šípková, DiS.

Anotace

V originále

AimsTo compare success rates and characteristics of smokers treated a second time by a smokers' clinic with success rates of their first treatment. DesignRetrospective cohort study. SettingTobacco Dependence Treatment clinic in Prague, Czech Republic, between 2005 and 2017. ParticipantsA total of 5225 smokers treated either once (n = 5006, single treatment sample, SS) or also second time (n = 219, re-treated sample, RS), on average 4.47 years after the first visit. InterventionSmokers received intensive treatment of tobacco dependence with pharmacotherapy options. Outcomes were evaluated after 1 year. In case of failure or relapse, participants could undergo re-treatment in the same setting at least 1 year after the start of the first treatment. MeasurementsTwelve-month self-reported continuous abstinence; CO-validated (<= 6 parts per million); number of visits; type of pharmacotherapy; mental health history; Fagerstrom Test for Cigarette Dependence; time between first and second treatment. ResultsThe abstinence rate in the SS was 34.8% [95% confidence interval (CI) = 33.4%, 36.1%] and in the RS was 37% (95% CI = 30.6%, 43.8%) and 39.7% (95% CI = 33.2%, 45.5%) for their first and second treatments, respectively. The samples were comparable on smoking and socio-demographic characteristics and pharmacotherapy used, but the RS in the second treatment had a higher prevalence of diagnosed mental health disorder at 39.3% (95% CI = 32.8%; 46.1%) compared with 23.7% (95% CI = 22.5%; 24.9%) in the SS. Participants who initiated their second quit attempt 1 to 2 years after the first one were less successful than those who initiated their second quit attempt later (25 versus 43%; P < 0.05). The results of the first treatment cycle were not found to be a reliable predictor for outcomes of the second cycle of treatment in univariate or multivariate logistic regression (odds ratio = 1.35, 95% CI = 0.70-2.63, P = 0.373). ConclusionIn Prague, Czech Republic, smokers re-attending stop-smoking treatment more than 2 years after their previous quit attempt appear to achieve similar success rates to those being treated for the first time.

Citovat

STEPANKOVA, Lenka, Eva KRALIKOVA, Kamila ZVOLSKA, Alexandra PANKOVA, Zuzana ADAMCEKOVA, Matyáš KUHN a Derek NOLAND. Comparison between success rates for smokers re-treated by a smokers' clinic and success rates for smokers treated for the first time. ADDICTION. HOBOKEN: WILEY, 2021, roč. 116, č. 2, s. 346-355. ISSN 0965-2140. Dostupné z: https://dx.doi.org/10.1111/add.15175.

@article{1678922,
   author = {Stepankova, Lenka and Kralikova, Eva and Zvolska, Kamila and Pankova, Alexandra and Adamcekova, Zuzana and Kuhn, Matyáš and Noland, Derek},
   article_location = {HOBOKEN},
   article_number = {2},
   doi = {http://dx.doi.org/10.1111/add.15175},
   keywords = {Mental health; nicotine; re-treatment; tobacco; tobacco dependence; tobacco use disorder; pharmacotherapy; varenicline},
   language = {eng},
   issn = {0965-2140},
   journal = {ADDICTION},
   note = {Absolvent: podíl doplněn rovnocenně podle počtu participujících HS (dle rozhodnutí vedení PřF).},
   title = {Comparison between success rates for smokers re-treated by a smokers' clinic and success rates for smokers treated for the first time},
   url = {https://onlinelibrary.wiley.com/doi/full/10.1111/add.15175},
   volume = {116},
   year = {2021}
}

TY  - JOUR
ID  - 1678922
AU  - Stepankova, Lenka - Kralikova, Eva - Zvolska, Kamila - Pankova, Alexandra - Adamcekova, Zuzana - Kuhn, Matyáš - Noland, Derek
PY  - 2021
TI  - Comparison between success rates for smokers re-treated by a smokers' clinic and success rates for smokers treated for the first time
JF  - ADDICTION
VL  - 116
IS  - 2
SP  - 346-355
EP  - 346-355
PB  - WILEY
SN  - 09652140
N1  - Absolvent: podíl doplněn rovnocenně podle počtu participujících HS (dle rozhodnutí vedení PřF).
KW  - Mental health
KW  - nicotine
KW  - re-treatment
KW  - tobacco
KW  - tobacco dependence
KW  - tobacco use disorder
KW  - pharmacotherapy
KW  - varenicline
UR  - https://onlinelibrary.wiley.com/doi/full/10.1111/add.15175
L2  - https://onlinelibrary.wiley.com/doi/full/10.1111/add.15175
N2  - AimsTo compare success rates and characteristics of smokers treated a second time by a smokers' clinic with success rates of their first treatment. DesignRetrospective cohort study. SettingTobacco Dependence Treatment clinic in Prague, Czech Republic, between 2005 and 2017. ParticipantsA total of 5225 smokers treated either once (n = 5006, single treatment sample, SS) or also second time (n = 219, re-treated sample, RS), on average 4.47 years after the first visit. InterventionSmokers received intensive treatment of tobacco dependence with pharmacotherapy options. Outcomes were evaluated after 1 year. In case of failure or relapse, participants could undergo re-treatment in the same setting at least 1 year after the start of the first treatment. MeasurementsTwelve-month self-reported continuous abstinence; CO-validated (<= 6 parts per million); number of visits; type of pharmacotherapy; mental health history; Fagerstrom Test for Cigarette Dependence; time between first and second treatment. ResultsThe abstinence rate in the SS was 34.8% [95% confidence interval (CI) = 33.4%, 36.1%] and in the RS was 37% (95% CI = 30.6%, 43.8%) and 39.7% (95% CI = 33.2%, 45.5%) for their first and second treatments, respectively. The samples were comparable on smoking and socio-demographic characteristics and pharmacotherapy used, but the RS in the second treatment had a higher prevalence of diagnosed mental health disorder at 39.3% (95% CI = 32.8%; 46.1%) compared with 23.7% (95% CI = 22.5%; 24.9%) in the SS. Participants who initiated their second quit attempt 1 to 2 years after the first one were less successful than those who initiated their second quit attempt later (25 versus 43%; P < 0.05). The results of the first treatment cycle were not found to be a reliable predictor for outcomes of the second cycle of treatment in univariate or multivariate logistic regression (odds ratio = 1.35, 95% CI = 0.70-2.63, P = 0.373). ConclusionIn Prague, Czech Republic, smokers re-attending stop-smoking treatment more than 2 years after their previous quit attempt appear to achieve similar success rates to those being treated for the first time.
ER  -

STEPANKOVA, Lenka, Eva KRALIKOVA, Kamila ZVOLSKA, Alexandra PANKOVA, Zuzana ADAMCEKOVA, Matyáš KUHN a Derek NOLAND. Comparison between success rates for smokers re-treated by a smokers' clinic and success rates for smokers treated for the first time. \textit{ADDICTION}. HOBOKEN: WILEY, 2021, roč.~116, č.~2, s.~346-355. ISSN~0965-2140. Dostupné z: https://dx.doi.org/10.1111/add.15175.

Podrobný výpis o publikaci